About Erasca, Inc. 
Erasca, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 35 Schemes (15.79%)
Foreign Institutions
Held by 74 Foreign Institutions (7.9%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-34 Million
Pharmaceuticals & Biotechnology
USD 2,851 Million ()
NA (Loss Making)
NA
0.00%
-0.81
-33.97%
8.20






